Coronary Artery Disease Clinical Trials in St Louis, Missouri

7 studies are recruiting for coronary artery disease in St Louis, Missouri right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

1. Product Surveillance Registry

   The purpose of the Registry is to provide continuing evaluation and periodic reporting of safety and effectiveness of Medtronic market-released products. The Registry data is intended to benefit and support interests of patients, hospitals, clinicians, regulatory bodies, payers, and industry by str…

   Stage

   Not phased

   Ages

   Any age

   Site

   Research site, St Louis, Missouri

   Locations

   401 in total

   Run by

   Medtronic

   See if you can join NCT01524276 on ClinicalTrials.gov

2. Pivotal Study of the SUpira System in Patients Undergoing High-Risk Percutaneous COronaRy InTervention (HRPCI)

   The objective of this study is to assess the safety and efficacy of the Supira System in providing temporary cardiovascular hemodynamic support in patients undergoing HRPCI. Eligible patients will be randomized to undergo HRPCI with either the Supira System (investigational device) or the commercia…

   Stage

   Not phased

   Ages

   18 to 90

   Site

   Washington University in St. Louis, St Louis, Missouri

   Locations

   19 in total

   Run by

   Supira Medical

   See if you can join NCT07296744 on ClinicalTrials.gov

3. A Phase 2b Clinical Trial of YN001 in Adults With Coronary Atherosclerosis

   This study is designed to evaluate the efficacy and safety of intravenously administered YN001 in patients diagnosed with coronary atherosclerosis, who are receiving background therapy for cardiovascular (CV) risk factors management.

   Stage

   Phase 2

   Ages

   18 to 80

   Site

   Washington University School of Medicine, St Louis, Missouri

   Locations

   40 in total

   Run by

   Beijing Inno Medicine Co., Ltd.

   See if you can join NCT07521007 on ClinicalTrials.gov

4. Safety and Effectiveness of the Orsiro Mission 48-mm Sirolimus Eluting Coronary Stent System in Subjects With Coronary Artery Lesions

   The purpose of the study is to assess the safety and efficacy of the Orsiro® Mission 48- mm Sirolimus-Eluting Coronary Stent System in the treatment of subjects with atherosclerotic lesion(s) >36 mm and ≤ 44 mm in length (by visual estimate) in the native coronary arteries with a reference vessel d…

   Stage

   Not phased

   Ages

   18 and older

   Site

   Barnes Jewish Hospital, St Louis, Missouri

   Locations

   23 in total

   Run by

   Teleflex

   See if you can join NCT06779630 on ClinicalTrials.gov

5. SELUTION 4 De Novo Small Vessel IDE Trial

   Prospective, randomized controlled, single-blind, multicenter, clinical trial to demonstrate the safety and efficacy of the SELUTION SLR 014 PTCA DEB for treatment of de novo lesions in small coronary vessels, defined as reference vessel diameter (RVD) of 2.00 mm to 2.75 mm, in support of a pre-mar…

   Stage

   Not phased

   Ages

   18 and older

   Site

   St. Louis Heart and Vascular, St Louis, Missouri

   Locations

   70 in total

   Run by

   M.A. Med Alliance S.A.

   See if you can join NCT05946629 on ClinicalTrials.gov

6. Comparison of the Outcomes of Single vs Multiple Arterial Grafts in Women

   The central hypothesis of ROMA:Women is that the use of multiple arterial grafting (MAG) will improve clinical outcomes and quality of life (QOL) compared to single arterial grafting (SAG). The specific aims of ROMA:Women are: Aim 1: Determine the impact of MAG vs SAG on major adverse cardiac and c…

   Stage

   Not phased

   Ages

   18 and older

   Site

   Washington University in St. Louis, St Louis, Missouri

   Locations

   146 in total

   Run by

   Weill Medical College of Cornell University

   See if you can join NCT04124120 on ClinicalTrials.gov

7. Staged Complete Revascularization for Coronary Artery Disease vs Medical Management Alone in Patients With AS Undergoing Transcatheter Aortic Valve Replacement

   Patients undergoing transcatheter aortic valve replacement (TAVR) often have concomitant coronary artery disease (CAD) which may adversely affect prognosis. There is uncertainty about the benefits and the optimal timing of revascularization for such patients. There is currently clinical equipoise r…

   Stage

   Not phased

   Ages

   Any age

   Site

   St. Louis University, St Louis, Missouri

   Locations

   72 in total

   Run by

   University of British Columbia

   See if you can join NCT04634240 on ClinicalTrials.gov